As a leading publisher of trusted science, technology, medicine, humanities and social sciences research, Taylor & Francis is committed to helping public health authorities, researchers, clinicians and the general public contain and manage the spread of COVID-19.
This microsite provides links and references to all relevant COVID-19 research articles, book chapters and information that can be freely accessed on Taylor & Francis Online and Taylor & Francis ebooks in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19. As signatories to NIH’s Access to Research initiative, along with the Wellcome Trust’s coordinated action on sharing research data and findings relevant to the outbreak, Taylor & Francis has been working with WHO to ensure this content is clearly signposted. We are also aligning the OSTP’s initiative to centralise resources on PubMed and are currently working with them to ensure rapid human and machine-readable access (where possible) to research articles and data through the NLM’s LitCovid portal.
More research in this field has been collated by colleagues at F1000Research, through a dedicated Gateway which showcases research published in this area, including preprints, to ensure immediate access to the latest research developments https://f1000research.com/gateways/disease_outbreaks/coronavirus
Prioritising rapid publication of COVID-19 materials
We are working with our editors to prioritise peer review of all relevant research. We are also focusing our workflow to ensure that materials related to the outbreak are fast-tracked through the publication process once they are approved. Editors are proactively encouraging authors to publish and share the data that forms the basis of their research in line with FAIR data principles, and our own data policies.
We are continually monitoring the developments of the coronavirus and spread of COVID-19, and we will continue to update the content on this site on a regular basis.
Updated to reflect the latest research on COVID-19, Dictionary of Drugs is now freely accessible until September 2020. The database presents accurate, up to date, and concise information on currently marketed drugs, drugs undergoing clinical trials, as well as pharmacological tools; this is a one-stop resource for the medicinal chemist. Dictionary of Drugs consists of 15,569 entries and 59,684 compounds.
Visit the site today and access the free resources
Journals
1-326 of 5,000+ results.
Access the full Coronavirus Research Archive
- research-articleIn silico designing of multi-epitope vaccine construct against human coronavirus infections
- research-articleIn silico virtual screening, characterization, docking and molecular dynamics studies of crucial SARS-CoV-2 proteins
- review-articleAcute respiratory distress syndrome: a life threatening associated complication of SARS-CoV-2 infection inducing COVID-19
- research-articlePredictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease
- research-articleConformational fingerprints in the modelling performance of MIA-QSAR: a case for SARS-CoV protease inhibitors
- research-articleDeciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods
- research-articleIdentification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study
- research-articleIdentification of potential drug candidates to combat COVID-19: a structural study using the main protease (mpro) of SARS-CoV-2
- research-articleAntiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19
- research-articleVirtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2
- research-articleIdentification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis
- research-articleMolecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2
- research-articleComputational drug repurposing for the identification of SARS-CoV-2 main protease inhibitors
- research-articleComparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study
- research-articleTargeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development
- research-articleDual inhibitors of SARS-CoV-2 proteases: pharmacophore and molecular dynamics based drug repositioning and phytochemical leads
- research-articleCyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis
- research-articleVirtual screening, molecular dynamics and structure–activity relationship studies to identify potent approved drugs for Covid-19 treatment
- research-articleIn-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors
- research-articleTargeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19
- research-articleThe latitude hypothesis, vitamin D, and SARS-Co-V2
- research-articleApproach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study
- research-articleDrug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)
- research-articleLoss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends
- research-articleComputational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease
- research-articleIdentification of potential drugs against SARS-CoV-2 non-structural protein 1 (nsp1)
- research-articleOn the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity
- research-articleNetwork pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
Books
- research-articleNatural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery
- research-articlePotential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis
- research-articleIdentification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor
- research-articleSuccessful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature
- research-articleScreening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study
- research-articleIn silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme
- editorialThe status surrounding chloroquine and other drugs as potential anti-infective agents for COVID-19
- research-articleRepurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease
- research-articleImmunoinformatics study to search epitopes of spike glycoprotein from SARS-CoV-2 as potential vaccine
- research-articleIn-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-19
- research-articleScreening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets
- research-articleRemdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease – in silico approach
- research-articlePromising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation
- research-articleIn silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2
- research-articleSars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach
- research-articleVirtual screening and dynamics of potential inhibitors targeting RNA binding domain of nucleocapsid phosphoprotein from SARS-CoV-2
- review-articleAdvances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19
- research-articleNatural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation
- research-articleLeucoefdin a potential inhibitor against SARS CoV-2 Mpro
- research-articleAn in silico approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease
- research-articleWithanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
- review-articleRepurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies
- research-articleDoes lopinavir measure up in the treatment of COVID-19?
- research-articleLopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection
- research-articleIdentification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies
- research-articleA computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem)
- research-articleAntiviral effects of probiotic metabolites on COVID-19
- reviewEffectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review
- research-articleIdentification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches
- research-articleStructural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor
- research-articleRepurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening
- research-articleWithanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity
- research-articleFragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease
- research-articleMarine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study
- review-articleThe expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets
- research-articleOld and re-purposed drugs for the treatment of COVID-19
- research-articleTopological Indices of Some Chemical Structures Applied for the Treatment of COVID-19 Patients
- review-articleRemdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary
- research-articleIdentification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
- research-articleTruncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
- research-articleIdentification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors
- review-articleDevelopment of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase
- research-articleMultifunctional nano-magnetic particles assisted viral RNA-extraction protocol for potential detection of COVID-19
- research-articleIn-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
- research-articleUsing integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2
- research-articleFDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication
- research-articleFatal Eosinophilic Myocarditis in a Healthy 17-Year-Old Male with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2c)
- research-articleClinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin–angiotensin system inhibitors
- research-articleIdentification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
- research-articleAn investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
- research-articleAn in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
- research-articleA molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2
- research-articlePeptide-like and small-molecule inhibitors against Covid-19
- research-articleRisk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort study
- research-articleMoroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
- research-articlePractical Considerations When Performing Neurodiagnostic Studies on Patients with COVID-19 and Other Highly Virulent Diseases
- research-articlePrediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count
- research-articleDiscovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
- research-articleAndrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
- research-articleUnderstanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures
- research-articleQuadruple therapy for asymptomatic COVID-19 infection patients
- research-articleReverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
- review-articleNovel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
- research-articleThe role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
- research-articleDrug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
- review-articleA review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
- research-articleAssociation between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study
- research-articleIn-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
- article-commentaryClinical observation and management of COVID-19 patients
- article-commentaryClinical observation and management of COVID-19 patients
- rapid-communicationEmerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments
- research-articleRNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak
- research-articleGenomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- article-commentaryAntibodies to watch in 2020
- research-articleRecombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
- case-reportFeline infectious peritonitis: answers to frequently asked questions concerning FIP and coronavirus
- research-articleEmerging infectious disease laboratory and diagnostic preparedness to accelerate vaccine development
- research-articleCharacterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China
- research-articleA sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus
- research-articleComparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea
- research-articleA novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
- Original ResearchStructural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
- research-articleGenomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats
- reviewCritical evaluation of FDA-approved respiratory multiplex assays for public health surveillance
- research-articleVaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus
- research-articleVaccines for epidemic infections and the role of CEPI
- research-articlePanblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
- article-commentaryRecent advancements in combination subunit vaccine development
- article-commentaryUnderstanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks — Implications for coronavirus vaccine development
- research-articleA novel variant of the infectious bronchitis virus resulting from recombination events in Italy and Spain
- research-articleA metagenomic comparison of endemic viruses from broiler chickens with runting-stunting syndrome and from normal birds
- reviewBiosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
- otherDynamics of avian coronavirus circulation in commercial and non-commercial birds in Asia – a review
- editorialClinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics
- editorialMiddle East respiratory syndrome: current status and future prospects for vaccine development
- review-articleCommunity-acquired pneumonia: An overview
- research-articleOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
- research-articleOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
- research-articleAnalysis of the complete genomic sequences of two virus subpopulations of the Australian infectious bronchitis virus vaccine VicS
- Original ResearchDesign of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach
- review-articleMolecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics
- review-articleMolecular isothermal techniques for combating infectious diseases: towards low-cost point-of-care diagnostics
- research-articleAirborne Microorganisms From Livestock Production Systems and Their Relation to Dust
- research-articleMultiplex PCR theranostics of severe respiratory infections
- research-articleRole of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease
- research-articleDownstream processing of cell culture-derived virus particles
- research-articleSARS vaccines: where are we?
- research-articleAdvantages of mRNA display selections over other selection techniques for investigation of protein–protein interactions
- research-articleMiniaturized detection technology in molecular diagnostics
- research-articleRoadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
- research-articleProtein microarrays: high-throughput tools for proteomics
- research-articleThe FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens
- research-articleExpecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
- research-articleDeveloping vaccines to counter bioterrorist threats
- editorialDevelopment of a SARS vaccine: an industrial perspective on the global race against a global disease
- research-articleExpecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
- research-articleSARS vaccines: where are we?
- review-articleTargeting CCL5 in inflammation
- research-articleAn experimental study of the survival of turkey coronavirus at room temperature and +4°C
- research-articleThe diversity of viruses infecting humans
- research-articleInfectious bronchitis virus variants: a review of the history, current situation and control measures
- review-articleCoronaviruses
- research-articleEfficacy and safety of an attenuated live QX-like infectious bronchitis virus strain as a vaccine for chickens
- review-articleDevelopment and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review
- research-articleA new genotype of nephropathogenic infectious bronchitis virus circulating in vaccinated and non-vaccinated flocks in China
- research-articleMolecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain
- research-articleInteraction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes
- research-articleThe isolation and Characterisation of six avian infectious bronchitis viruses isolated in morocco
- research-articleAntigenic and immunogenic characterization of infectious bronchitis virus strains isolated in China between 1986 and 1995
- research-articleLithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture
- research-articlePotential therapies for coronaviruses
- research-articleAntiviral applications of RNAi for coronavirus
- review-articleThe role of reverse genetics in the development of vaccines against respiratory viruses
- review-articleThe role of reverse genetics in the development of vaccines against respiratory viruses
